On September 7, 2022 Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, reported it will be featured as a presenting company at the H.C. Wainwright 24th Annual Global Investment Conference on September 13, 2022, at 2:00 pm Eastern Time (Press release, Applied DNA Sciences, SEP 7, 2022, https://adnas.com/apdn-to-present-at-h-c-wainwright-24th-annual-global-investment-conference/ [SID1234619146]). The conference is being held as a hybrid in-person/virtual event from September 12 to 14, 2022.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Applied DNA’s CEO and Chairman of the Board of Directors, Dr. James A. Hayward, will present in person and provide an overview of the Company’s business during the presentation.
To listen to a livestream of the Company’s presentation, please click on the following link to register for the conference: Applied DNA presentation at the H.C. Wainwright 24th Annual Global Investment Conference